Cargando…

Granulomatous hepatitis in a healthy adult after bacillus Calmette–Guérin injection into a plantar wart

Detalles Bibliográficos
Autores principales:	Moon, Do Sik, Choi, Woo Young, Yoon, Na-Ra, Kim, Dong-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683750/ https://www.ncbi.nlm.nih.gov/pubmed/29159252 http://dx.doi.org/10.1016/j.jdcr.2017.07.008

Ejemplares similares

Granulomatous hepatitis as a rare complication of Bacillus Calmette-Guérin vaccination
por: Shoaran, Maryam, et al.
Publicado: (2013)

The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
por: Gupta, Sunil Kumar
Publicado: (2020)

Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin
por: Soylu, Aliye, et al.
Publicado: (2009)

Hepatic Injury without Granulomatous Formation Associated with Intravesical Bacillus Calmette-Guérin Therapy
por: Okano, Hiroshi, et al.
Publicado: (2019)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
por: Ghafouri, Sayed Ab. Reshad, et al.
Publicado: (2018)

Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette–Guérin for Treatment of Bladder Cancer
por: Branco, Elsa Alves, et al.
Publicado: (2021)

Excellent Response to Intralesional Bacillus Calmette-Guérin Vaccine in a Recalcitrant Periungual Wart
por: Kumar, Piyush, et al.
Publicado: (2014)

Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
por: Jaisinghani, Avtar Kishan, et al.
Publicado: (2019)

The Bacillus Calmette-Guérin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Yassen, Asaad Q., et al.
Publicado: (2020)

Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2021)

Why Intralesional Measles-Mumps-Rubella is Superior to Bacillus Calmette-Guérin for Treatment of Warts?
por: Al-Qassabi, Al Mutasim, et al.
Publicado: (2022)

Systemic Granulomatous Reaction Secondary to Treatment of Bladder Cancer with Bacillus Calmette-Guerin
por: Valentini, Caterina Giovanna, et al.
Publicado: (2012)

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
por: Gao, Cindy Q, et al.
Publicado: (2011)

Re: The Bacillus Calmette-Guerin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Mendalawi, Mahmood D.
Publicado: (2021)

Imaging Patterns of Bacillus Calmette–Guérin-Related Granulomatous Prostatitis Based on Multiparametric MRI
por: Lee, Seungsoo, et al.
Publicado: (2022)

Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China
por: Li, Tao, et al.
Publicado: (2019)

Mesenteric abscess caused by coinfection with Bacillus Calmette-Guérin and Phialemonium sp. in chronic granulomatous disease
por: Miyazawa, Hanae, et al.
Publicado: (2022)

Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation: A case report
por: Moussa, M., et al.
Publicado: (2018)

Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021)

Systemic Bacillus Calmette–Guerin infection secondary to inadvertent intravenous injection
por: Farooq, Mudasir, et al.
Publicado: (2021)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
por: Bernatowska, Ewa Anna, et al.
Publicado: (2007)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)

100 years of the Bacillus Calmette-Guérin vaccine
por: Bettencourt, Paulo J.G., et al.
Publicado: (2021)

Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022)

Acute Hepatitis and Pneumonitis Caused by Disseminated Bacillus Calmette-Guérin Infection
por: Dibs, Khaled, et al.
Publicado: (2016)

Comparative prostate MRI before and after chronic granulomatous prostatitis following intravesical bacillus Calmette–Guérin therapy
por: Sarkis, Julien, et al.
Publicado: (2020)

Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)

Bacillus Calmette-Guérin vaccination, thymic size, and thymic output in healthy newborns
por: Birk, Nina Marie, et al.
Publicado: (2017)

Multiphase Contrast-Enhanced Magnetic Resonance Imaging Features of Bacillus Calmette-Guérin-Induced Granulomatous Prostatitis in Five Patients
por: Kawada, Hiroshi, et al.
Publicado: (2015)

THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICE
por: Blanden, R. V., et al.
Publicado: (1969)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Sternal Osteomyelitis after Bacillus Calmette-Guérin Vaccination
por: Selvestravičius, Rolandas, et al.
Publicado: (2016)

Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020)

COVID-19 and Bacillus Calmette-Guérin: What is the Link?
por: Hegarty, Paul K., et al.
Publicado: (2020)

Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease
por: Klein, Benjamin Y., et al.
Publicado: (2022)

Generalized Granuloma Annulare in Infancy Following Bacillus Calmette-Guerin Vaccination
por: Lee, Sang Woo, et al.
Publicado: (2011)

Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_n3rr84a44pv4avasl1ctlm98jc